Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 534

Related Articles by Review for PubMed (Select 15756426)

1.
2.

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.

Harris RE.

Inflammopharmacology. 2009 Apr;17(2):55-67. doi: 10.1007/s10787-009-8049-8. Review.

PMID:
19340409
3.

Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.

Moran EM.

J Environ Pathol Toxicol Oncol. 2002;21(2):193-201. Review.

PMID:
12086406
5.

Epidemiology of non-steroidal anti-inflammatory drugs and cancer.

Baron JA.

Prog Exp Tumor Res. 2003;37:1-24. Review.

PMID:
12795046
6.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

7.

Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.

Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.

Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):5-26. Review.

PMID:
12852480
8.

Dual acting anti-inflammatory drugs: a reappraisal.

Bertolini A, Ottani A, Sandrini M.

Pharmacol Res. 2001 Dec;44(6):437-50. Review.

PMID:
11735348
10.

Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.

Reddy BS, Rao CV.

J Environ Pathol Toxicol Oncol. 2002;21(2):155-64. Review.

PMID:
12086402
11.

Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.

Steele VE, Hawk ET, Viner JL, Lubet RA.

Mutat Res. 2003 Feb-Mar;523-524:137-44. Review.

PMID:
12628511
13.

COX selectivity and animal models for colon cancer.

Oshima M, Taketo MM.

Curr Pharm Des. 2002;8(12):1021-34. Review.

PMID:
11945149
14.

Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.

Bertolini A, Ottani A, Sandrini M.

Curr Med Chem. 2002 May;9(10):1033-43. Review.

PMID:
12733982
15.

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.

Ballinger A, Smith G.

Expert Opin Pharmacother. 2001 Jan;2(1):31-40. Review.

PMID:
11336566
17.
18.

Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.

Buskens CJ, Ristimäki A, Offerhaus GJ, Richel DJ, van Lanschot JJ.

Scand J Gastroenterol Suppl. 2003;(239):87-93. Review.

PMID:
14743889
19.

The medicinal chemistry implications of the anticancer effects of aspirin and other NSAIDs.

Gardiner PS, Gilmer JF.

Mini Rev Med Chem. 2003 Aug;3(5):461-70. Review.

PMID:
12769697
20.

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

DuBois RN, Giardiello FM, Smalley WE.

Gastroenterol Clin North Am. 1996 Dec;25(4):773-91. Review.

PMID:
8960892
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk